About this trial
This study evaluates different factors that determine the treatment choice and treatment compliance in patients with central sleep apnea. All patients will receive routine care (registry).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years old
An apnea/hypopnea index ≥ 15/h of sleep and proportion of non-obstructive events > 50%, derived from polysomnography (diagnostic or during (PAP) treatment)
Written informed consent provided
Disqualifiers
None
Trial population
Subjects with an apnea/hypopnea index ≥ 15/h of sleep and proportion of non-obstructive events \> 50%, derived from polysomnography (diagnostic or during positive airway pressure treatment)
Trial design
Cohort
Prospective
Treatments tested in this trial
No intervention
Other interventionRoutine care (registry)
Treatment groups
Trial outcomes
Primary outcomes
Treatment choice
Proportion of patients treated with the different treatment modalities
Secondary outcomes
Factors determining treatment choice
Relation between patient and CSA characteristics and the treatment choice
Treatment compliance
Compliance to the different treatment modalities
Short Form 36 Health Survey
To measure eight domains of health Content: * physical functioning * role limitations due to physical health * bodily pain * general health perceptions * vitality * social functioning * role limitations due to emotional problems * mental health Number of items: 36 items are included in scoring Score interpretation: each item scored on a 0 to 100 range so that the lower and highest possible scores are set at 0 and 100. Scores represent the percentage of total possible score achieved.
Pitssburgh Sleep Quality index
To measure sleep quality and disturbances. Score range: 0-21 points, with lower scores indicating better sleep quality.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universitaire Ziekenhuizen KU Leuven
Lead sponsor
Philips Respironics
Collaborator